AKSO HEALTH GROUP
(NASDAQ: AHG)
|
4:59 PM UTC, 07/03/24 | |||
---|---|---|---|---|
Last: $1.16 | Change: +0.33 | %Change: +40.51% | Volume: 520,015 |
Open: | $ 0.86 | Volume: | 520,015 | |
---|---|---|---|---|
High: | $ 1.22 | Yield(%) | 0.00 | |
Low: | $ 0.86 | P/E Ratio (ttm): | n/a | |
Dividend ($): | 0.38 | Market Cap ($): | 18.75M | |
EPS ($) | -1.50 | Shares Out: | 22.87M |
% Price Change (last 4 weeks): | -23.18 |
---|---|
% Price Change (last 13 weeks): | -25.27 |
% Price Change (last 26 weeks): | -27.26 |
% Price Change (last 52 weeks): | 152.53 |
% Price Change (year to date): | 10.81 |
Return on Equity (%): | -125.63 |
---|---|
Return on Assets (%): | -37.10 |
Return on Invested Capital (%): | -94.98 |
Gross Profit Margin (%): | 9.66 |
---|---|
Net Profit Margin (%): | -100.08 |
Operating Profit Margin (%): | -108.19 |
|
|
50-day Moving Average: | $0.85 |
---|---|
200-day Moving Average: | $1.11 |
Avg. Daily Vol. (last 50 days): | 35,237 |
Avg. Daily Vol. (last 200 days): | 88,454 |
52-wk high: | $2.90 |
52-wk low: | $0.25 |
Bid: | $1.28 |
Ask: | $1.36 |
Akso Health Group operates a social e-commerce platform principally in China that collaborates with other domestic e-commerce platforms and offers users a wide selection of products. It also plans to develop a new business as a cancer therapy and radiotherapy oncology service provider with operations in the U.S. The firm plans to open 2 vaccine research centers and 100 radiation oncology centers to be located on the east coast serving cancer patients in need of varying stages of treatment, including specialized radiation therapy centers for radiotherapy, personalized consultation, conventional treatment planning, and other cancer related treatment services. The company was founded by Xiaobo An in March 2014 and is headquartered in Beijing, China.
|
AKSO HEALTH GROUP
Room 515, Floor 5 Jia No. 92-4 to 24 Jianguo Road Chaoyang District Beijing BE 100020 Phone: 86.10.5370.9902 Fax: n/a http://www.xiaobaimaimai.com |
Earnings (1year) ($): | -0.23 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 0.38 |
Cash Flow ($): | -0.06 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | 0.62 |
Price/Book (x): | 0.93 |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | n/a |
---|---|
Current Ratio (x): | n/a |
LT Debt/Equity (x): | 0.00 |
Total Debt/Equity (x): | 0.00 |